BPC-157 is a novel research chemical that exists in the form of a peptide chain consisting of 15 amino acids. Seeing as it isn’t biosynthesized or a product of any living substance it is classified as a synthetic. It is derived from a protective protein found in the stomach.
To date, researchers have conducted several rodent studies on BPC-157. These seem to suggest it has protective effects, primarily gastroprotective, but seeming to extend beyond the stomach and intestinal tract. BPC-157 has been beneficial in cases of stomach ulcers, intestinal damage, fistulas and inflammatory disorders. It also seems to have collagen regenerating potential assisting in bone and joint healing and growth rates, and speeding some organ damage recovery. It also seems to have some influence on the brain.
Currently its still unknown whether there are multiple mechanisms of action in this peptide chain’s actions. The mechanisms themselves are not fully understood but certain theories about the gut-brain axis are prevalent in current models for how the pentadecapeptide works. There seem to be several separate growth factors involved in angiogenesis (formation of new blood vessels) and factors related to healing, regrowth and regeneration after tissue damage.
Current studies show much promise, but BPC-157 is currently unstudied in humans, with no clinical trials to date. Human studies will be necessary in order to demonstrate the efficacy and safety of these benefits are extended beyond the research animals such as rodents and chicken embryos.
Most current studies on BPC-157 are based on rat trials. The rats were generally injected with a solution of the peptide chain. While BPC-157 is considered a stable peptide, peptides are somewhat volatile. In addition peptides are generally poorly absorbed with oral supplementation. Certain trials also refer to BPC by the name Bepecin, PL-10 or PL 14736.
As mentioned earlier, there are currently no pharmacokinetic studies done on humans to assess potential species differences so these are just estimates. The BPC in the pentadecapeptide, stands for “Body Protection Compounds” which refers to “peptides comprising 8-15 amino acids residues with a molecular weight of 900-1,600 daltons” [1]. Another study however, claims BPC refers to a specific gastroprotective protein that was used to isolate BPC-157. BPC-157 is sourced from the endogenous protein Thymosin beta 4, or TB-500.
All peptides contain some sequence of the 15 amino acids. While making them seemingly “natural” products as a result, this particular sequence of aminos does not occur in nature and can’t be synthesized in vivo (in the body) and is therefore considered a synthetic peptide. Peptides are a basic chain of code for our body, other well known peptides include noopept for instance.
BPC-157 is easily soluble in wate.[5] The exact sequenced of amino acids in the pentadecapeptide, BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val[5] It is considered exceptionally for a peptide, as it doesn’t break down immediately in gastric acid. A chick embryo assay study showed a possible mechanism for BPC involving angiogenesis through an increase in VEGFR2 expression. Injured rats were given BPC-157. Compared to control, VEGFR2 increased. VEGFR2 inhibitors seemed to deactivate this action suggesting that the VEGFR2 pathway may be vital to the angiogenesis effect. This is an important part of what activates the protein code involved in blood vessel repair and new blood vessel creation.
BPC also seems to have a stimulator effect on Mrna of the growth factor EGR-1, EGF-1 and other endogenous growth factors within intestinal cells.
When incubated in plasma ex vivo, it appears that a large amount of the peptide detected is registered as ‘metabolites’ (79+/-2%) of the parent compound within 60 minutes, although it then seems to stabilize, with the remaining intact peptide remaining for up to 240 minutes.[3]
BPC may have some dopaminergic effects, it seems to at least limit the efficacy of dopamine agonists, based on a trial involving amphetamine and haloperidol co-administered with the peptide. Serotonergic effect of BPC may be a reason for its possible positive effect regarding depression and chronic stress and anxiety. It is theorized this is due to the brain-intestines (gut/serotonin) axis since BPC has an effect in both areas. Once again though, the full mechanisms and how they work are not fully understood.
BPC-157 may also have protective effects on brain tissue. Rats administered the neurotoxin cuprizone had reduced cell damage in multiple regions of the brain when offered BPC as a therapeutic intervention. In these tests, BPC was orally ingested. Rats with a chronic unpredictable stress model had their stress and depression model alleviated with the administration of BPC after forced swim tests.
In addition to it’s neuroprotective and gastroprotective qualities, BPC may have a positive effect on collagen, tendons, bone. In sponge studies, BPC seemed to improve the rate of collagen reformation, as well as rats with Achilles heel injury. These studies suggest that tendon regenesis could be aided by BPC-157.
BPC-157, also known as Body Protection Compound 157, is a peptide that was discovered in the late 1990s. It is a chain of amino acids that is derived from a naturally occurring protein found in the gastric juices of humans. BPC-157 has gained attention for its potential use in medical and scientific applications due to its unique properties.
BPC-157 is known for its ability to promote tissue healing and regeneration. This peptide has been shown to have a positive effect on the healing of wounds, fractures, and ligament injuries. It has also been shown to have a positive effect on the healing of various other types of tissue damage, including nerve damage and muscle damage.
One of the key factors that makes BPC-157 such a promising peptide is its ability to stimulate cell growth and regeneration. This is due to the fact that BPC-157 has been shown to have a positive effect on the activity of certain enzymes that are involved in the growth and repair of tissues. This has led to the development of numerous studies exploring the potential of BPC-157 to be used in the treatment of various conditions, including chronic wounds, osteoarthritis, and spinal cord injuries.
Another important property of BPC-157 is its ability to reduce inflammation. Inflammation is a key factor in many medical conditions, including arthritis, heart disease, and cancer. BPC-157 has been shown to have a positive effect on the reduction of inflammation in animal models, and this has led to numerous studies exploring its potential use in the treatment of these conditions.
BPC-157 has also been shown to have a positive effect on the protection of cells from oxidative damage. Oxidative damage is a key factor in the development of many age-related diseases, including Alzheimer’s disease and Parkinson’s disease. By protecting cells from oxidative damage, BPC-157 has the potential to be used in the treatment of these conditions.
In addition to its ability to promote tissue healing and regeneration, BPC-157 has also been shown to have a positive effect on the function of the immune system. This is due to the fact that BPC-157 has been shown to have a positive effect on the activity of certain immune cells, including natural killer cells and T-cells. This has led to numerous studies exploring the potential of BPC-157 to be used in the treatment of autoimmune diseases and other conditions that are associated with a compromised immune system.
BPC-157 is also known for its ability to protect cells from the harmful effects of certain chemicals. This includes the harmful effects of drugs that are used in cancer treatment, such as chemotherapy and radiation therapy. By protecting cells from the harmful effects of these drugs, BPC-157 has the potential to be used in the development of new cancer treatments that are more effective and less toxic.
Another important property of BPC-157 is its ability to protect cells from damage caused by stress. Stress is a key factor in the development of many medical conditions, including depression, anxiety, and cardiovascular disease. BPC-157 has been shown to have a positive effect on the protection of cells from the harmful effects of stress, and this has led to numerous studies exploring its potential use in the treatment of these conditions.
BPC-157 has also been shown to have a positive effect on the metabolism of fat. This is due to the fact that BPC-157 has been shown to have a positive effect on the activity of certain enzymes that are involved in the metabolism of fat. This has led to numerous studies exploring the potential of BPC-157 to be used in the treatment of obesity and other conditions that are associated with metabolic dysfunction.
BPC-157 is a peptide with a unique sequence of amino acids. It is a 15-amino acid peptide that is derived from a naturally occurring protein found in the gastric juices of humans. The structure of BPC-157 is defined by the sequence of its amino acids, which are linked together by peptide bonds. The exact sequence of BPC-157 is: GLY-GLN-GLY-PRO-PRO-PRO-GLN-PRO-ARG-ARG-ARG-GLY-PRO-PRO-PRO. This sequence determines the chemical and physical properties of the peptide, including its stability, solubility, and activity. The structure of BPC-157 is important for understanding its potential uses and limitations in various applications, including medical and scientific research.
BPC-157 is a peptide that has been shown to have a number of effects in the body. It is believed to act through several mechanisms to promote tissue healing and regeneration, reduce inflammation, protect cells from oxidative damage, and enhance immune function.
One of the ways that BPC-157 works in the body is by promoting tissue healing and regeneration. It has been shown to stimulate the growth and repair of various types of tissue, including wounds, fractures, and ligament injuries. This is due to its ability to stimulate the activity of certain enzymes that are involved in the growth and repair of tissues.
Another way that BPC-157 works in the body is by reducing inflammation. Inflammation is a key factor in many medical conditions, including arthritis, heart disease, and cancer. BPC-157 has been shown to have a positive effect on the reduction of inflammation in animal models, and this is believed to be due to its ability to inhibit the activity of certain inflammatory cytokines.
BPC-157 also works in the body by protecting cells from oxidative damage. Oxidative damage is a key factor in the development of many age-related diseases, including Alzheimer’s disease and Parkinson’s disease. BPC-157 has been shown to have a positive effect on the protection of cells from oxidative damage, and this is believed to be due to its ability to enhance the activity of antioxidants.
In addition to these effects, BPC-157 has also been shown to enhance immune function. It has been shown to have a positive effect on the activity of certain immune cells, including natural killer cells and T-cells. This is believed to be due to its ability to regulate the activity of these cells and enhance their ability to fight infection and disease.
Overall, BPC-157 is a peptide that has a number of effects in the body. Its ability to promote tissue healing and regeneration, reduce inflammation, protect cells from oxidative damage, and enhance immune function make it a promising candidate for the development of new medical treatments.
BPC-157 is known to promote angiogenesis, which is the growth of new blood vessels. Angiogenesis is an important process in the body, as it helps to increase blood flow to tissues and organs, which is necessary for their survival and function. BPC-157 has been shown to stimulate the growth of new blood vessels in animal models, which is believed to be due to its ability to stimulate the activity of certain growth factors involved in angiogenesis.
This ability of BPC-157 to promote angiogenesis has led to its investigation as a potential treatment for various medical conditions that are associated with poor blood flow and inadequate angiogenesis, such as ischemic heart disease and peripheral artery disease. BPC-157 has also been investigated as a potential treatment for wounds and injuries, as it has been shown to improve blood flow and support the growth of new blood vessels in these areas, which can speed up the healing process.
However, it is important to note that while BPC-157 has been shown to promote angiogenesis in animal models, more research is needed to determine its safety and efficacy in human subjects. Further studies are needed to understand the mechanisms by which BPC-157 promotes angiogenesis and its potential benefits and risks in various medical conditions.
Limitless Life Nootropics’ BPC-157 is offered in it’s crystalline, powder form in a sterilized brown glass Boston round bottle with a sprayer and medicine syringe for application and stirring.
https://pubmed.ncbi.nlm.nih.gov/21030672/
https://onlinelibrary.wiley.com/doi/abs/10.1016/S0736-0266(03)00110-4
https://pubmed.ncbi.nlm.nih.gov/16609979/
https://pubmed.ncbi.nlm.nih.gov/10071911/
https://josr-online.biomedcentral.com/articles/10.1186/s13018-019-1242-6
https://pubmed.ncbi.nlm.nih.gov/20225319/
https://www.sciencedirect.com/science/article/abs/pii/S0928425797894806
https://examine.com/supplements/bpc-157/#bone-and-joint-health
